BIT
EPZM

BlackRock Institutional Trust’s Epizyme, Inc EPZM Stock Holding History

BlackRock Institutional Trust’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$11.7M Buy
968,109
+100,225
+12% +$1.05M ﹤0.01% 2310
2016
Q3 		$8.54M Buy
867,884
+39,585
+5% +$361K ﹤0.01% 2428
2016
Q2 		$8.48M Buy
828,299
+2,443
+0.3% +$27.2K ﹤0.01% 2389
2016
Q1 		$10M Buy
825,856
+234,168
+40% +$2.37M ﹤0.01% 2257
2015
Q4 		$9.48M Buy
591,688
+19,097
+3% +$283K ﹤0.01% 2359
2015
Q3 		$7.36M Buy
572,591
+205,060
+56% +$4.14M ﹤0.01% 2488
2015
Q2 		$8.82M Buy
367,531
+173,836
+90% +$3.35M ﹤0.01% 2487
2015
Q1 		$3.64M Buy
193,695
+61,821
+47% +$1.28M ﹤0.01% 2863
2014
Q4 		$2.49M Sell
131,874
-1,497
-1% -$35K ﹤0.01% 3015
2014
Q3 		$3.62M Sell
133,371
-8,723
-6% -$271K ﹤0.01% 2822
2014
Q2 		$4.42M Buy
142,094
+57,920
+69% +$1.36M ﹤0.01% 2838
2014
Q1 		$1.92M Buy
84,174
+16,027
+24% +$486K ﹤0.01% 3180
2013
Q4 		$1.42M Sell
68,147
-66,177
-49% -$1.92M ﹤0.01% 3284
2013
Q3 		$5.37M Buy
134,324
+43,519
+48% +$1.47M ﹤0.01% 2698
2013
Q2 		$2.55M Buy
+90,805
New +$2.33M ﹤0.01% 2972

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Institutional Trust's EPZM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Epizyme, Inc (EPZM) stake by 12% in Q4 2016, buying an estimated $1.05M and bringing the position to 968,109 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2310.

BlackRock Institutional Trust first reported a position in EPZM in Q2 2013 and has held it in 15 quarters since. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

  • BlackRock Institutional Trust held 968,109 shares of Epizyme, Inc worth $11.7M as of Q4 2016.
  • BlackRock Institutional Trust bought 100,225 Epizyme, Inc shares in Q4 2016, an estimated $1.05M.
  • Epizyme, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2310 holding.
  • BlackRock Institutional Trust first reported a position in Epizyme, Inc in Q2 2013 and has held it in 15 quarters since.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.